免疫脂质体,immunoliposomes
1)immunoliposomes免疫脂质体
1.ADM-loaded immunoliposomes reverse MDR of human lung carcinoma in vitro;MRK-16修饰阿霉素免疫脂质体逆转肺癌细胞多药耐药研究
2.The Comparison between the Action of DHAQ-anti-CD45 RAMcAb Immunoliposomes and DHAQ-GM-CSF Immunoliposomes on HL60 Cell;DHAQ-anti-CD45RAMcAb免疫脂质体和DHAQ-GM-CSF免疫脂质体分别作用于HL60细胞的比较
3.Preparation and Pharmaceutical Quality Evaluation of Nattokinase Immunoliposomes and Its Lyophilized Product纳豆激酶免疫脂质体及其冻干品的制备及药剂学性质评价
英文短句/例句

1.Preparation of Immunoliposomes and Their Application in Laboratory Diagnosis;免疫脂质体的制备及在实验诊断中的应用
2.Preparation and Pharmaceutical Quality Evaluation of Nattokinase Immunoliposomes and Its Lyophilized Product纳豆激酶免疫脂质体及其冻干品的制备及药剂学性质评价
3.Preparation and Antitumor Effects of Monoclonal Antibody Targeted Immunoliposomes upon Human Gastric Cancer in Vitro and in Vivo;胃癌特异性免疫脂质体导向治疗的体内外实验研究
4.Biodistribution Study on MA-GM-CSF Liposome in Mice with Human Leukemia;MA-GM-CSF免疫脂质体在白血病小鼠体内的组织分布
5.Preparation and Targetibility of Antitumor Immunoliposomes Entrapping ADM Bearing Anti-VEGF Ab;阿霉素免疫脂质体对膀胱癌细胞的体外杀伤研究
6.Preparation of ADM-loaded Immunoliposomes and Reversion of MDR of Human Lung Carcinoma in Vitro;阿霉素免疫脂质体的制备与体外逆转肺癌细胞多药耐药研究
7.Prelimanary study of the preparation and character of immunoliposome loading polypeptide PEDF with ATWLPPR as ligand modified on the surfaceATWLPPR配体修饰的载多肽药物PEDF免疫脂质体的制备和表征初步研究
8.Radiosensitivity of Lovo Cell Enhanced by Immunoliposomal Docetaxel;多烯紫杉醇免疫脂质体对Lovo细胞的靶向放射增敏研究
9.Targeted Therapy to SCID Mice with Human Acute Myelocytic Leukemia Using GM-CSF-MA Liposomeons;GM-CSF-MA免疫脂质体靶向治疗人AML小鼠模型的实验研究
10.Targeted and thrombolytic effect of urokinase-loaded immunoliposomes on acute pulmonary embolism in rabbits尿激酶免疫脂质体对肺栓塞家兔的靶向溶栓治疗作用
11.Preparation of iRNA Liposomes and Studies on Its Immunologic Effects;免疫核糖核酸脂质体的制备及其免疫作用研究
12.Preparation of Immunoglobulin G Lipsomes from Milk Fat Globule Membrane Phospholipids乳脂肪球膜磷脂-免疫球蛋白G脂质体的制备
13.Study on Preparation of Liposome-encapsulated Influenza Split Vaccine and Its Immunity Evaluation;脂质体流感疫苗的制备及免疫效果评价
14.Preparation and immunogenicity of influenza vaccine lyophilized liposomes流感疫苗脂质体冻干粉的制备及其免疫原性
15.Cellular and Humoral Immune Responses to Cervix Carcinoma in Mice Induced by Liposomal Crude Butanol Extraction(CBE)-based Vaccine;U_(14)-CBE脂质体瘤苗诱导的细胞和体液免疫应答
16.Studies on Effects of Immunotherapy with BCG Liposome on Liver Tumor in Rats;卡介苗脂质体免疫治疗大鼠肝癌的实验研究
17.The Influence of Defatting on Immunogenicity and Osteogenicity of Cancellous Bone Allograft;脱脂对异体松质骨免疫原性和成骨能力的影响
18.Immunosuppressive effect of paclitaxel liposome on B lymphocytes紫杉醇脂质体B细胞免疫抑制作用的实验研究
相关短句/例句

immunoliposome免疫脂质体
1.Study on the anticancer activity in vitro of carmofur immunoliposome specifically against human colorectal carcinoma;大肠癌特异性卡莫氟免疫脂质体的体外抗癌活性研究
2.Preparation of Immunoliposomes and Their Application in Laboratory Diagnosis;免疫脂质体的制备及在实验诊断中的应用
3.Prelimanary study of the preparation and character of immunoliposome loading polypeptide PEDF with ATWLPPR as ligand modified on the surfaceATWLPPR配体修饰的载多肽药物PEDF免疫脂质体的制备和表征初步研究
3)Cisplatin immunoliposome顺铂免疫脂质体
4)sterically stabilized immunoliposome空间稳定免疫脂质体
1.Sterically stabilized immunoliposome for brain targeting can bring drugs into brain directed by specific monoclonal antibody.介绍了脑靶向空间稳定免疫脂质体制剂的研究进展。
2.Objective To study the preparation methods,physical and chemical properties of the islet neogenesis-associated protein (INGAP) sterically stabilized immunoliposomes.目的以肝细胞生长因子为包被对象,研究胰岛新生相关蛋白(INGAP)空间稳定免疫脂质体的制备方法、理化性质和体外靶向性。
5)Liposome immunoassay(LIA)脂质体-免疫分析法
6)liposome immunosensor脂质体免疫传感器
延伸阅读

多相脂质体139 , 三氨酸多相脂质体,油酸多相脂质体注射液药物名称:油酸多相脂质体注射液英文名:Polyphase Liposome-139别名: 139;多相脂质体139 , 三氨酸多相脂质体,油酸多相脂质体注射液外文名:Polyphase Liposome-139适应症: 用于治疗各种消化管癌(如胃癌、结肠癌、肝癌、胰腺癌、食管癌等)、肺癌、淋巴肉瘤、乳腺癌等。 用量用法: 开始时1日量20ml,如无不良反应,逐渐增大剂量,最多可至1日50ml,加入氯化钠注射液中(250~500ml)混匀,缓缓静滴,滴速控制在每分钟40~60滴,每日1次,1个疗程总量1200~1500ml。如单用本品,1个疗程结束后,休息1周,进行复查,然后继续第2疗程。如是手术病人,术后2周开始维持给药,1日50ml,每周2次,用1个月。本品亦可与化疗或放疗合用,先用本品1疗程,休息1周后,,再按常规使用化疗或放疗,可减轻化疗药物的毒副作用,提高机体免疫功能。 注意事项: 1.用前将注射液振摇均匀后与等渗盐水混匀。 2.偶有面部发热,仅需减慢滴速即能恢复正常。 3.禁用于直接静脉推注,以免危险。 4.开始用药2~3日内白细胞可能略有下降,继续给药随即回升至正常水平。 规格: 针剂:10ml。 类别:其他抗肿瘤药及辅助治疗药